Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome (Q39261907)

10 September 2017

title

Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome (English)

1 reference

10 September 2017

1

1 reference

10 September 2017

2

Amy P Abernethy

1 reference

10 September 2017

language of work or name

English

0 references

publication date

28 January 2014

1 reference

10 September 2017

1 reference

10 September 2017

volume

10

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

789-802

1 reference

Cachexia as a major underestimated and unmet medical need: facts and numbers

10 September 2017

cites work

1 reference

Definition and classification of cancer cachexia: an international consensus

21 January 2018

1 reference

Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment

21 January 2018

1 reference

Cancer cachexia pathophysiology and translational aspect of herbal medicine

21 January 2018

1 reference

Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies

21 January 2018

1 reference

Understanding the mechanisms and treatment options in cancer cachexia

21 January 2018

1 reference

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

21 January 2018

1 reference

Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated Fatty acids in the management of symptoms, survival, and quality of life

21 January 2018

1 reference

Antibodies to watch in 2013: Mid-year update

21 January 2018

1 reference

Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia/cachexia

21 January 2018

1 reference

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

21 January 2018

1 reference

Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome

21 January 2018

1 reference

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal c

21 January 2018

1 reference

Examination of the tissue ghrelin expression of rats with diet-induced obesity using radioimmunoassay and immunohistochemical methods.

21 January 2018

1 reference

Ghrelin in the regulation of body weight and metabolism

21 January 2018

1 reference

Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone

21 January 2018

1 reference

Ghrelin octanoylation mediated by an orphan lipid transferase

21 January 2018

1 reference

Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice

21 January 2018

1 reference

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

A role for ghrelin in the central regulation of feeding

21 January 2018

1 reference

Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.

21 January 2018

1 reference

Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing

21 January 2018

1 reference

Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model

21 January 2018

1 reference

Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers

21 January 2018

1 reference

Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers

21 January 2018

1 reference

ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome

21 January 2018

1 reference

Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort.

21 January 2018

1 reference

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.14.14

1 reference

release_77thiltbgjbrxpdwezstfur2be

10 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/77thiltbgjbrxpdwezstfur2be

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference